Please assess the completion status of the following clinical trial:

Trial Title: Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 18-65 years, male or female~* Elective liver transplantation~* United Network for Organ Sharing (UNOS) Level 2A/B or 3~* Serum albumin ≥ 30 g/L~* Comprehend all the procedures of this study~* Willing and able to give informed consent~Exclusion Criteria:~* Uncontrolled exo-hepatic malignant carcinomas~* Uncontrollable infections (including HIV infection)~* Need support of artificial liver or kidney, ventilator-dependant, coma or unstable hemodynamically~* Patients with a history of hypersensitivity to hydroxyethyl starch or albumin~* Urinary output less than 500 ml within 24 hours after operation~* Patients with intracranial bleeding~* Patients with other colloids for treating hypovolemia~* Patients with pulmonary edema~* Pregnant women or females of childbearing potential and lactating mothers~* Patients who are participating in other drug studies or who receive other investigational drugs within 30 days prior to the present study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).